flavone acetic acid has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clavel, M; Dodion, P; Gundersen, S; Kaye, SB; Monfardini, S; Renard, J; Smith, J; Stoter, G; ten Bokkel-Huinink, W; Wagener, DT | 1 |
| Delforge, AR; Dethier, NE; Dodion, PF; Kenis, Y; Loos, M; Sanders, C; Schroyens, WA; Stryckmans, PA | 1 |
2 other study(ies) available for flavone acetic acid and Breast Cancer
| Article | Year |
|---|---|
Phase II trials with flavone acetic acid (NCS. 347512, LM975) in patients with advanced carcinoma of the breast, colon, head and neck and melanoma.
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Flavonoids; Head and Neck Neoplasms; Humans; Melanoma; Middle Aged | 1990 |
In vitro chemosensitivity testing of flavone acetic acid (LM975; NSC 347512) and its diethylaminoethyl ester derivative (LM985; NSC 293015).
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Survival; Colonic Neoplasms; Colony-Forming Units Assay; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Flavonoids; Head and Neck Neoplasms; Humans; Leukemia; Tumor Cells, Cultured | 1987 |